Year |
Citation |
Score |
2005 |
Nimmrich V, Maier N, Schmitz D, Draguhn A. Induced sharp wave-ripple complexes in the absence of synaptic inhibition in mouse hippocampal slices. The Journal of Physiology. 563: 663-70. PMID 15661820 DOI: 10.1113/Jphysiol.2004.079558 |
0.336 |
|
2005 |
Nimmrich V, Hargreaves EL, Muslimov IA, Bianchi R, Tiedge H. Dendritic BC1 RNA: modulation by kindling-induced afterdischarges. Brain Research. Molecular Brain Research. 133: 110-8. PMID 15661371 DOI: 10.1016/J.Molbrainres.2004.10.008 |
0.524 |
|
2004 |
Muslimov IA, Nimmrich V, Hernandez AI, Tcherepanov A, Sacktor TC, Tiedge H. Dendritic transport and localization of protein kinase Mzeta mRNA: implications for molecular memory consolidation. The Journal of Biological Chemistry. 279: 52613-22. PMID 15371429 DOI: 10.1074/Jbc.M409240200 |
0.482 |
|
2000 |
Xiang Z, Hrabetova S, Moskowitz SI, Casaccia-Bonnefil P, Young SR, Nimmrich VC, Tiedge H, Einheber S, Karnup S, Bianchi R, Bergold PJ. Long-term maintenance of mature hippocampal slices in vitro. Journal of Neuroscience Methods. 98: 145-54. PMID 10880828 DOI: 10.1016/S0165-0270(00)00197-7 |
0.469 |
|
Low-probability matches (unlikely to be authored by this person) |
2008 |
Nimmrich V, Grimm C, Draguhn A, Barghorn S, Lehmann A, Schoemaker H, Hillen H, Gross G, Ebert U, Bruehl C. Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 788-97. PMID 18216187 DOI: 10.1523/Jneurosci.4771-07.2008 |
0.258 |
|
2003 |
Maier N, Nimmrich V, Draguhn A. Cellular and network mechanisms underlying spontaneous sharp wave-ripple complexes in mouse hippocampal slices. The Journal of Physiology. 550: 873-87. PMID 12807984 DOI: 10.1113/Jphysiol.2003.044602 |
0.227 |
|
2009 |
Nimmrich V, Ebert U. Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid. Reviews in the Neurosciences. 20: 1-12. PMID 19526730 |
0.212 |
|
2005 |
Barghorn S, Nimmrich V, Striebinger A, Krantz C, Keller P, Janson B, Bahr M, Schmidt M, Bitner RS, Harlan J, Barlow E, Ebert U, Hillen H. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. Journal of Neurochemistry. 95: 834-47. PMID 16135089 DOI: 10.1111/J.1471-4159.2005.03407.X |
0.198 |
|
2008 |
Nimmrich V, Szabo R, Nyakas C, Granic I, Reymann KG, Schröder UH, Gross G, Schoemaker H, Wicke K, Möller A, Luiten P. Inhibition of Calpain Prevents N-Methyl-D-aspartate-Induced Degeneration of the Nucleus Basalis and Associated Behavioral Dysfunction. The Journal of Pharmacology and Experimental Therapeutics. 327: 343-52. PMID 18701765 DOI: 10.1124/jpet.108.142679 |
0.193 |
|
2013 |
Hermann D, Mezler M, Müller MK, Wicke K, Gross G, Draguhn A, Bruehl C, Nimmrich V. Synthetic Aβ oligomers (Aβ(1-42) globulomer) modulate presynaptic calcium currents: prevention of Aβ-induced synaptic deficits by calcium channel blockers. European Journal of Pharmacology. 702: 44-55. PMID 23376566 DOI: 10.1016/J.Ejphar.2013.01.030 |
0.182 |
|
2010 |
Granic I, Nyakas C, Luiten PG, Eisel UL, Halmy LG, Gross G, Schoemaker H, Möller A, Nimmrich V. Calpain inhibition prevents amyloid-beta-induced neurodegeneration and associated behavioral dysfunction in rats. Neuropharmacology. 59: 334-42. PMID 20650285 DOI: 10.1016/j.neuropharm.2010.07.013 |
0.161 |
|
2015 |
Nimmrich V, Draguhn A, Axmacher N. Neuronal Network Oscillations in Neurodegenerative Diseases. Neuromolecular Medicine. PMID 25920466 DOI: 10.1007/S12017-015-8355-9 |
0.152 |
|
2010 |
Hillen H, Barghorn S, Striebinger A, Labkovsky B, Müller R, Nimmrich V, Nolte MW, Perez-Cruz C, van der Auwera I, van Leuven F, van Gaalen M, Bespalov AY, Schoemaker H, Sullivan JP, Ebert U. Generation and therapeutic efficacy of highly oligomer-specific beta-amyloid antibodies. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 10369-79. PMID 20685980 DOI: 10.1523/JNEUROSCI.5721-09.2010 |
0.149 |
|
2021 |
Naseri Kouzehgarani G, Feldsien T, Engelhard HH, Mirakhur KK, Phipps C, Nimmrich V, Clausznitzer D, Lefebvre DR. Harnessing Cerebrospinal Fluid Circulation for Drug Delivery to Brain Tissues. Advanced Drug Delivery Reviews. PMID 33705875 DOI: 10.1016/j.addr.2021.03.002 |
0.109 |
|
2015 |
Brown JW, Moeller A, Schmidt M, Turner SC, Nimmrich V, Ma J, Rueter LE, van der Kam E, Zhang M. Anticonvulsant effects of structurally diverse GABAB positive allosteric modulators in the DBA/2J audiogenic seizure test: Comparison to baclofen and utility as a pharmacodynamic screening model. Neuropharmacology. 101: 358-369. PMID 26471422 DOI: 10.1016/J.Neuropharm.2015.10.009 |
0.098 |
|
2019 |
Jantos K, Kling A, Mack H, Hornberger W, Moeller A, Nimmrich V, Lao Y, Nijsen M. Discovery of ABT-957: 1-Benzyl-5-oxopyrrolidine-2-carboxamides as selective calpain inhibitors with enhanced metabolic stability. Bioorganic & Medicinal Chemistry Letters. PMID 31133534 DOI: 10.1016/j.bmcl.2019.05.034 |
0.09 |
|
2023 |
Jacobson PB, Mothe A, Levy A, Krakovsky M, Hooker BA, Zhang X, Mollon J, Mordashova Y, Droescher M, Weiss S, Barghorn S, Dreher I, Awwad K, Nimmrich V, Huang L, et al. Neutralizing RGMa with Elezanumab Promotes Cerebroprotection and Recovery in Rabbit Middle Cerebral Artery Occlusion. Translational Stroke Research. PMID 37326791 DOI: 10.1007/s12975-023-01164-2 |
0.088 |
|
2017 |
Kling A, Jantos K, Mack H, Hornberger W, Drescher K, Nimmrich V, Relo A, Wicke K, Hutchins CW, Lao Y, Marsh KC, Moeller A. Discovery of Novel and Highly Selective Inhibitors of Calpain for the Treatment of Alzheimer´s Disease: 2-(3-Phenyl-1H-pyrazol-1-yl)nicotinamides. Journal of Medicinal Chemistry. PMID 28759231 DOI: 10.1021/acs.jmedchem.7b00731 |
0.07 |
|
2013 |
Hermann D, Mezler M, Swensen AM, Bruehl C, Obergrußerger A, Wicke K, Schoemaker H, Gross G, Draguhn A, Nimmrich V. Establishment of a secondary screening assay for P/Q-type calcium channel blockers. Combinatorial Chemistry & High Throughput Screening. 16: 233-43. PMID 23228050 DOI: 10.2174/1386207311316030008 |
0.065 |
|
2012 |
Mezler M, Hermann D, Swensen AM, Draguhn A, Terstappen GC, Gross G, Schoemaker H, Freiberg G, Pratt S, Gopalakrishnan SM, Nimmrich V. Development and validation of a fluorescence-based HTS assay for the identification of P/Q-type calcium channel blockers. Combinatorial Chemistry & High Throughput Screening. 15: 372-85. PMID 22272661 DOI: 10.2174/138620712800194503 |
0.058 |
|
Hide low-probability matches. |